Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 377

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1A
Chunk 377
---
 applications which may later result in issued patents that our product candidates may
infringe that we are not aware of. In addition, third parties may obtain patents in the future and claim that use of our technologies
infringes upon these patents. If any third-party patents were held by a court of competent jurisdiction to cover any of our product
candidates, the holders of any such patents may be able to block our ability to commercialize such product candidate unless we obtained
a license under the applicable patents, or until such patents expire. Similarly, if any third-party patent were held by a court of competent
jurisdiction to cover aspects of our formulations, processes for manufacture or methods of use, including combination therapy, the holders
of any such patent may be able to block our ability to develop and commercialize the applicable product candidate unless we obtained a
license or until such patent expires. In either case, such a license may not be available on commercially reasonable terms or at all.
Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact
on our business. In addition, we may be subject to claims that we are infringing other intellectual property rights, such as trademarks
or copyrights, or misappropriating the trade secrets of others, and to the extent that our employees, consultants or contractors use intellectual
property or proprietary information owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and
inventions, which could be time-consuming and divert the attention of senior management.

Parties making claims against us may obtain injunctive or other
equitable relief, which could effectively block our ability to further develop and commercialize one or more of our product candidates.
Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion
of employee resources from our business, as well as potentially be liable for substantial, or even treble, damages.

Persons may seek injunctive or other equitable relief, which may prevent
us from continuing to develop and commercialize our product candidates. The defense costs to such actions are substantial and require
management and other knowledge employees to divert their attention from existing operations to defending such claims. In the event of
a successful infringement or other intellectual property claim against it, we may have to pay substantial damages, including treble damages
and attorneys’ fees for willful infringement, obtain one or more licenses from third parties, pay royalties or